» Articles » PMID: 36128858

Radiomics Features Based on MRI-ADC Maps of Patients with Breast Cancer: Relationship with Lesion Size, Features Stability, and Model Accuracy

Overview
Journal Medeni Med J
Specialty General Medicine
Date 2022 Sep 21
PMID 36128858
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To predict breast cancer molecular subtypes with neural networks based on magnetic resonance imaging apparent diffusion coefficient (ADC) radiomics and to detect the relation of lesion size with the stability of radiomics features.

Methods: This retrospective study included 221 consecutive patients (224 lesions) with breast cancer imaged between January 2015 and January 2020. Three sample size configurations were identified based on tumor size (experiment 1: all cases, experiment 2: >1 cm, and experiment 3: >2 cm). The tumors were segmented by three observers based on diffusion-weighted imaging-registered ADC maps, and the volumetric agreement of these segmentations was evaluated using the Dice coefficient. Stability of radiomics features (n=851) was evaluated with intraclass correlation coefficient (ICC, >0.75) and coefficient of variation (CoV, <0.15). Feature selection was made with variance inflation factor (VIF, <10) and least absolute shrinkage and selection operator regression. Outcomes were identified as molecular subtypes (Luminal A, Luminal B, HER2-enriched, triple-negative). Neural network performance was presented as an area under the curve and accuracies.

Results: Of the 851 radiomics features, 611 had ICC >0.75, and 37 remained stable in the first experiment, 49 in the second, and 59 in the third based on CoV and VIF analysis. High accuracy was demonstrated by the Luminal B, HER2-enriched, and triple-negative models in the first experiment (>80%), all models in the second experiment, and HER2-enriched and triple-negative models in the third experiment.

Conclusions: A positive stability is indicated by an increased lesion size related to radiomics features. Neural networks may predict moleculer subtypes of breast cancers over 1 cm with high accuracy.

Citing Articles

Noninvasive imaging signatures of HER2 and HR using ADC in invasive breast cancer: repeatability, reproducibility, and association with pathological complete response to neoadjuvant chemotherapy.

Teng X, Zhang J, Zhang X, Fan X, Zhou T, Huang Y Breast Cancer Res. 2023; 25(1):77.

PMID: 37381020 PMC: 10308682. DOI: 10.1186/s13058-023-01674-9.


Artificial Intelligence in the Diagnosis and Treatment of Pancreatic Cystic Lesions and Adenocarcinoma.

Jiang J, Chao W, Culp S, Krishna S Cancers (Basel). 2023; 15(9).

PMID: 37173876 PMC: 10177524. DOI: 10.3390/cancers15092410.


Freehand 1.5T MR-Guided Vacuum-Assisted Breast Biopsy (MR-VABB): Contribution of Radiomics to the Differentiation of Benign and Malignant Lesions.

Tagliafico A, Calabrese M, Brunetti N, Garlaschi A, Tosto S, Rescinito G Diagnostics (Basel). 2023; 13(6).

PMID: 36980315 PMC: 10047866. DOI: 10.3390/diagnostics13061007.

References
1.
Pisco A, Huang S . Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: 'What does not kill me strengthens me'. Br J Cancer. 2015; 112(11):1725-32. PMC: 4647245. DOI: 10.1038/bjc.2015.146. View

2.
Kocak B, Durmaz E, Ates E, Kilickesmez O . Radiomics with artificial intelligence: a practical guide for beginners. Diagn Interv Radiol. 2019; 25(6):485-495. PMC: 6837295. DOI: 10.5152/dir.2019.19321. View

3.
Goldhirsch A, Winer E, Coates A, Gelber R, Piccart-Gebhart M, Thurlimann B . Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2013; 24(9):2206-23. PMC: 3755334. DOI: 10.1093/annonc/mdt303. View

4.
Koo T, Li M . A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016; 15(2):155-63. PMC: 4913118. DOI: 10.1016/j.jcm.2016.02.012. View

5.
Li H, Zhu Y, Burnside E, Huang E, Drukker K, Hoadley K . Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set. NPJ Breast Cancer. 2016; 2. PMC: 5108580. DOI: 10.1038/npjbcancer.2016.12. View